The Valpharma Group makes available its own experience and technologies in favour of prospective partners interested in the research, development and industrial manufacture of:
- tablets or dragée in modified release form ( i.e. enteric coated, enteric coated plus slow release or slow release form);
- pellets (=beadlets, microspheres) for hard gelatine capsules in modified release form.
The development of the individual formulations includes the realization of the technical dossiers needed for the registrations with the Health Authorities worldwide.
- Core Sales Territory:
Global Regulated Markets